Daewoong Pharmaceutical Co., Ltd (DAEWOONG PHARM) aksje
069620.KS
Forsinket 20 min₩123,800.00-2,700.00 (-2.13%)
Laster graf...
DAEWOONG PHARM
Market Cap
$1,424,476,209,152
Åpning127,200.00
Høy129,100.00
Lav123,300.00
Volum4.17k
P/EN/A
Markedsverdi1.42T
52-ukers høy199,400.00
52-ukers lav122,000.00
Gj.sn. volum31.65k
Utbytte0.47%
Beta0.07
EPSN/A
Om Daewoong Pharmaceutical Co., Ltd (DAEWOONG PHARM) aksje
Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.
Selskapsinformasjon
Børs: KSE (KSC)
Sektor: Sundhed
Industri: Lægemiddelproducenter – Special og generisk
Adresse:
12, Bongeunsa-ro 114-gil
135-715 Seoul, South Korea
135-715 Seoul, South Korea
Telefon: + 82 2 550 8209
Nettside: https://www.daewoong.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Anbefaling:1.55 - Køb
Laveste kursmål
200,000.00
↑ 61.6%
Gjennomsnittlig kursmål
207,272.73
↑ 67.4%
Median kursmål
210,000.00
↑ 69.6%
Høyeste kursmål
220,000.00
↑ 77.7%